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Introduction
Proteases of the AAA+ superfamily play critical roles in protein quality control, in signaling, in control of cell division, and in regulating transcriptional responses to stress in all organisms (Ogura and Wilkinson, 2001; Striebel et al., 2009; Sauer and Baker, 2011) . Escherichia coli has five AAA+ proteases: HslUV, ClpXP, ClpAP, FtsH, and Lon. Despite differences in structure and substrate specificity, these proteases share a common mechanism in which a hexameric AAA+ ring harnesses the energy of ATP binding and hydrolysis to recognize, unfold, and translocate substrates through an axial pore and into the degradation chamber of the peptidase. Most bacterial proteins are targeted for degradation via short terminal peptide sequences, known as degrons. For example, the seven N-terminal residues of the Arc protein are required for degradation by HslUV (Sundar et al., 2012) .
The HslUV protease consists of the hexameric AAA+ unfoldase HslU and the dodecameric HslV peptidase and is involved in the degradation of substrates during heat shock, the DNAdamage response, and other stresses (Rohrwild et al., 1996; Kanemori et al., 1997; Seong et al., 1999; Wu et al., 1999; Bochtler et al., 2000; Sousa et al., 2000; Kuo et al., 2004) . In model substrates, both N-and C-terminal sequences can affect the kinetics of degradation by HslUV, suggesting that multi-degron recognition by different binding sites in the HslU hexamer regulates substrate selection (Kwon et al., 2004; Burton et al., 2005; Koodathingal et al., 2009; Lien et al., 2009; Sundar et al., 2010; . HslUV can initiate degradation of appropriately tagged fusion proteins from either terminus, but it is unclear if degron position alone is responsible for controlling the directionality of degradation (Sundar et al., 2012; Kwon et al., 2003 , Koodathingal et al., 2009 . Interestingly, HslUV appears to (Koodathingal et al., 2009) , suggesting that directionality may also be an important factor in substrate degradation in vivo.
HslU contains a unique auxiliary domain, called the intermediate or I domain, that emerges from the top of the AAA+ ring following the Walker-A ATPase motif and GYVG translocation loop of each subunit and reconnects with the ring just before the Walker-B motif (Bochtler et al., 2000; Sousa et al., 2000) . Deletion of this domain severely depresses ATP hydrolysis and prevents substrate degradation by HslUV (Kwon et al., 2003; Sundar et al., 2012) . In HslU and HslUV crystal structures, electron density for I-domain residues 177-212 is absent or extremely poor (Bochtler et al., 2000; Sousa et al., 2000; Wang et al., 2001a) , indicating that these amino acids adopt multiple conformations with respect to the crystal lattice. Based on flanking regions, the 177-212 segment appears to be positioned near the top of a funnel-like cavity leading to the axial translocation pore of HslU (Fig. 1A) . Indeed, deleting these residues or replacing them with a linker results in reduced substrate binding and alters the coupling between substrate binding and ATP hydrolysis (Sundar et al., 2012) . A Leu 199 →Gln mutation in this region abolishes HslUV degradation of several substrates in vivo (Lien et al., 2009 ), but the mechanism by which it affects HslUV function is unknown. Here, we characterize the L199Q HslU and L199Q HslUV enzymes and show that the structured regions of the mutant and wild-type enzymes and their interactions with HslV are essentially identical. Compared to WT HslUV, however, L199Q HslUV has substantially elevated ATP-hydrolysis, degrades some substrates more rapidly, and preferentially degrades model substrates from the opposite terminus. Thus, a structurally dynamic region of the Idomain modulates substrate specificity, regulates ATP hydrolysis, and controls the direction of substrate degradation.
Results

L199Q enhances ATP hydrolysis and HslV binding
In a multiple sequence alignment of 783 HslU orthologs (POA6H5 from http:// gremlin.bakerlab.org/ecoli.php), the position corresponding to residue 199 in E. coli HslU is a mid-sized hydrophobic residue, typically Leu, Ile, or Met (Fig. 1B) . As the Leu 199 →Gln mutation prevents HslUV degradation of several substrates in E. coli (Lien et al., 2009) , Leu 199 appears to play an important role in HslU structure and/or function. We purified the E. coli L199Q HslU mutant with an N-terminal H 6 tag (called L199Q HslU hereafter) and assayed rates of ATP hydrolysis for this enzyme and wild type ( WT HslU) in the presence and absence of the HslV peptidase. Notably, L199Q HslU hydrolyzed ATP at a rate ∼2.5-fold faster than WT HslU, and HslV substantially enhanced the ATP-hydrolysis rate for both the mutant and wild-type enzymes (Fig. 1C) . We titrated increasing concentrations of L199Q HslU or WT HslU against a fixed concentration of HslV, assayed changes in the rate of cleavage of a tripeptide that HslV alone degrades poorly, and fit the resulting curves to obtain apparent binding constants (Fig. 1D ). L199Q HslU bound HslV more tightly (78 nM) than WT HslU (180 nM) and also supported higher maximal peptidase activity. In combination, these results suggest that the degradation defect associated with L199Q HslU in vivo does not arise from impaired HslV binding or from defects in ATP hydrolysis in the L199Q HslUV complex.
L199Q HslUV and WT HslUV have similar structures
We examined ATPγS-bound L199Q HslUV and WT HslUV by negative-stain electron microscopy. In these experiments, most images were side views of singly capped (HslU 6 •HslV 12 ) or doubly capped (HslU 6 •HslV 12 •HslU 6 ) complexes. As shown in Fig. 2A , two-dimensional class averages of L199Q HslUV and WT HslUV were extremely similar. We also crystallized the L199Q HslUV complex in the presence of ATP and a high concentration of ammonium sulfate at 4 °C. Surprisingly, the unit-cell dimensions and space group of this crystal, which diffracted to 3.3 Å resolution, were almost identical to those of a crystal of WT HslUV grown in the presence of dATP from a low-salt buffer at 20 °C (1G4A.pdb; Wang et al., 2001a ; Table 1 ). After phasing by molecular replacement, we refined the L199Q HslUV structure to a model with excellent geometry and good R and R free values given the moderate resolution (Table 1) . We also re-refined the 1G4A structure to improve the statistics and geometry (Table 1) . For both the mutant and wild-type structures, crystallographic symmetry generated an HslU hexamer and an associated HslV dodecamer, which were nearly identical in the mutant and wild-type complexes ( Fig. 2B-D ; RMSD 0.62 Å for 4270 common Cα atoms). The main differences were in the I domain, where the maximum RMSD was 2.4 Å, but the wild-type I domains in some HslU structures differ by substantially larger values. Electron density for the I-domain segment containing residue 199 and flanking sequences was absent in both L199Q HslU and WT HslU. These results establish that L199Q HslU and WT HslU adopt the same basic hexameric structure and interact with HslV in the same fashion in the crystal lattice. In the active site of each L199Q HslU subunit, a simulated-annealing omit map showed electron density for ADP but no density for the γ-phosphate of ATP (Fig. 2E) , suggesting that ATP hydrolysis occurred during crystallization.
L199Q HslU is more sensitive to limited proteolysis
To probe potential differences in the structurally dynamic regions of the mutant and wildtype I domains, we performed limited proteolysis time courses monitored by SDS-PAGE. In the presence of ATP, subtilisin cleaved L199Q HslU substantially faster than WT HslU both in the absence and presence of HslV (Fig. 3A, 3B ). Subtilisin cleavage of WT HslU and L199Q HslU performed in the presence of ADP or absence of nucleotide gave results similar to the ATP experiments (not shown). Whether HslV was present or not, the early major products of L199Q HslU cleavage had molecular weights of ∼25 kDa, suggesting cleavage within the I domain, which includes residues 110-240 in the intact 443-residue enzyme. We isolated major proteolytic product(s) of L199Q HslU cleavage by subtilisin by anion-exchange chromatography, cleaved with trypsin, and analyzed the peptides by LC MS/MS sequencing. This analysis identified peptides corresponding to L199Q HslU residues 199-210 and 201-210, whose N-terminal sequences are inconsistent with generation by tryptic cleavage (Fig. 3C) . Thus, subtilisin appears to cleave L199Q HslU after Gln 198 and Gln 200 , which flank the site of the L199Q mutation. Chymotrypsin also cleaved L199Q HslU more rapidly than WT HslU (Fig. 3D) . As the cleavage specificities of chymotrypsin and subtilisin differ, these results suggest that the L199Q mutation affects limited proteolysis by altering the local structure or dynamics of the I domain rather than by introducing new cleavage sites. MALDI-TOF mass spectrometry of the major L199Q HslU chymotryptic products gave masses close to those expected for one fragment extending from the Nterminus to Phe 203 (expected 23, 906 Da; observed 23, 858 Da) and second fragment extending from Gln 204 to the C-terminus (expected 26, 618 Da; observed 26, 593 Da) . To confirm that chymotryptic cleavage of L199Q HslU occurred between Phe 203 and Gln 204 , we excised the top band of the doublet near 25 kDa and subjected it to sequential Edman degradation. The resulting sequence, Gln-Asn-Leu-Gly-Gly-Gln, corresponded to HslU residues 204-209.
L199Q HslUV is an active protease
To probe degradation activity, we initially used a circularly permuted variant of superfolder GFP ( cp6 GFP) with a C-terminal st11-ssrA sequence and an N-terminal Arc sequence (Milla et al., 1993; Nager et al., 2011) . Arc is normally dimeric and is a good HslUV substrate (Bowie et al., 1989; Burton et al., 2005) . Steady-state rates of degradation of different concentrations of Arc-cp6 GFP-st11-ssrA by L199Q HslUV and WT HslUV substrate were quantified by loss of native fluorescence of the cp6 GFP module and fit to the MichaelisMenten equation to determine K M and V max values ( Fig. 4A ; Table 2 ). Compared to WT HslUV, V max was ∼7-fold slower for L199Q HslUV and the catalytic efficiency (V max /K M ) was ∼3-fold lower. For both enzymes, degradation was ATP dependent and deletion of the Arc portion of the substrate prevented degradation (not shown). We also assayed degradation of I37A Arc-cp6 GFP-st11-ssrA ( Fig. 4B ; Table 2 ), in which the I37A mutation results in natively unfolded monomeric Arc . For this substrate, V max values were similar for both enzymes, and the wild-type catalytic efficiency was about twice that of the mutant. Thus, the degree of impairment of the mutant protease depends on the substrate.
We determined rates of ATP hydrolysis in the presence of near saturating concentrations of Arc-cp6 GFP-st11-ssrA or I37A Arc-cp6 GFP-st11-ssrA to calculate the number of ATPs hydrolyzed per molecule of substrate degraded (Fig. 4C ). For dimeric Arc-cp6 GFP-st11-ssrA, the energetic cost of L199Q HslUV degradation was ∼11-fold higher than the wild-type value, suggesting that the mutant enzyme requires a substantially greater average number of power strokes to successfully degrade this substrate. For monomeric I37A Arc-cp6 GFP-st11-ssrA, by contrast, L199Q HslUV was only 1.7-fold less efficient than WT HslUV. Thus, the Nterminal degron plays a role in determining the magnitude of energetic defect for L199Q HslUV degradation.
C-terminal sequences appended to Arc can also affect HslUV degradation (Kwon et al., 2004; Sundar et al., 2010; . We constructed Arc-cys-st11-ssrA and Arc-cys-st11-sul20 substrates, where sul20 corresponds to the C-terminal 20 residues of E. coli SulA (Gur and Sauer, 2009 ). We labeled the cysteines in these substrates with an Alexa-488 dye (designated cysA), and used changes in autoquenching to determine K M and V max values for L199Q HslUV and WT HslUV degradation (Table 2) . For Arc-cysA-st11-ssrA degradation, L199Q HslUV had a slightly higher V max than WT HslUV, but WT HslUV had a 3-fold higher catalytic efficiency because of a substantially lower K M . Addition of a monomeric SspB variant (McGinness et al., 2007) , which binds specifically to the ssrA tag, reduced the rate of WT HslUV degradation of Arc-cysA-st11-ssrA by ∼2-fold but almost completely eliminated degradation by L199Q HslUV (Fig. 4D) . Thus, the C-terminal region of Arc-cysA-st11-ssrA seems to be more important for degradation by L199Q HslUV.
Interestingly, for degradation of Arc-cysA-st11-sul20, L199Q HslUV had a higher V max and a higher catalytic efficiency than WT HslUV (Table 2) . Thus, the kinetic defects associated with L199Q HslUV degradation are suppressed when sul20 is the targeting degron.
Because native Arc dimers are relatively unstable thermodynamically and kinetically (Bowie and Sauer, 1989; , we tested whether the sul20 degron could target more stable substrates for preferential L199Q HslUV degradation. The Asn 11 side chains in the Arc dimer are close in space, and a Cys 11 -Cys 11 disulfide dramatically stabilizes the dimer (Robinson and Sauer, 2000) . We constructed N11C Arc-st11-sul20 and crosslinked the Cys 11 side chains with a bismaleimide, resulting in marked stabilization to GuHCl denaturation (Fig. 5A) . Strikingly, as assayed by SDS-PAGE, L199Q HslUV degraded crosslinked NC11 Arc-st11-sul20 ∼10-fold faster than did WT HslUV (Fig. 5B) . Several additional experiments also show that L199Q HslUV has robust unfolding activity. Fusion of Arc to a Gcn4 coiled-coil peptide increases the thermodynamic stability of both proteins by ∼4.5 kcal/mol (Baytshtok et al., 2015) . L199Q HslUV degraded Arc-Gcn4-st11-sul20 ∼5-fold faster than WT HslUV (Fig. 5C ), but this difference was less than 2-fold for Arc-Gcn4-st11-ssrA ( Fig. 5D ). To confirm that degradation by L199Q HslUV was faster than degradation by WT HslUV for these three substrates, we performed two additional independent replicates for the experiments shown in Fig. 5B -5D, quantified degradation by densitometry of the gels, fit each kinetic curve to a single exponential, and determined average rates and errors (Fig. 5E ). We also found that a cp7 variant of superfolder GFP-sul20 (Nager et al., 2011; Wohlever et al., 2013) was degraded far more rapidly by L199Q HslUV than by WT HslUV (Fig. 5F ). Collectively, these results show that the sul20 degron enhances degradation by L199Q HslUV to a greater extent than degradation by WT HslUV, and support a model in which C-terminal sequences play a major role in directing L199Q HslUV degradation.
L199Q changes the preferred direction of degradation
Many of our results could be explained if the L199Q mutation alters the preferred direction of HslUV degradation. To test this model, we used substrates for which degradation from either protein terminus was possible. N11C Arc-st11-sul20 contains a single cysteine near the N-terminus, and Arc-cys-st11-sul20 contains a single cysteine near the C-terminus. We labeled the cysteines in these substrates with biotin-maleimide and added streptavidin to bind the biotin. As assayed by SDS-PAGE, the substrate with streptavidin bound near the Nterminus was degraded substantially faster by L199Q HslUV than by WT HslUV (Fig. 6A) . By contrast, the substrate with streptavidin bound near the C-terminus was degraded ∼2-fold faster by WT HslUV than by L199Q HslUV (Fig. 6B) .
We also assayed degradation of Arc-DHFR-barnase-st11-sul20 in the presence of methotrexate, which stabilizes the DHFR domain and slows or blocks its degradation (Lee et al., 2001; Koodathingal et al., 2009 ). Strikingly, we observed accumulation of different truncation products for WT HslUV and L199Q HslUV, supporting opposite directional preferences (Fig. 6C) . The major product of WT HslUV degradation (product 1) was only a few kDa smaller than the full-length substrate (∼44 kDa), as expected if WT HslUV initiates degradation from the N-terminus, degrades part of Arc (∼6 kDa), and stalls upon encountering DHFR. By contrast, the major product of L199Q HslUV degradation (product 2) was ∼30 kDa, a size expected if L199Q HslUV initiates degradation from the C-terminus, degrades most of barnase (∼16 kDa), and stalls upon encountering DHFR. A minor and slightly smaller band (product 3) also accumulated during L199Q HslUV degradation, which probably represents degradation from both the C-terminus and N-terminus, leaving a product slightly larger than DHFR. Likewise, a very faint band of the same size was observed during WT HslUV degradation, suggesting that the wild-type enzyme can also degrade this substrate from the C-terminus, albeit very inefficiently. Thus, although both the wild-type and mutant enzymes can initiate degradation of Arc-DHFR-barnase-st11-sul20 from either end, WT HslUV preferentially degrades this substrate from the N-terminus, whereas L199Q HslUV preferentially degrades it from the C-terminus.
Discussion
The L199Q substitution in the I domain of HslU was initially reported as a loss-of-function mutation (Lien et al., 2009 ), and we do find that L199Q HslUV is a less-active protease for some protein substrates. More importantly, however, this point mutation elevates the rate of ATP hydrolysis, results in much faster HslUV proteolysis of some protein substrates, and changes whether degradation is preferentially initiated at the substrate N-or C-terminus. These dramatic functional changes are not associated with major structural changes in the HslUV complex. For example, the L199Q mutation does not detectably change the structure of the hexameric AAA+ ring of HslU, which is responsible for ATP-fueled substrate unfolding and translocation. Similarly, the L199Q mutation does not disrupt the interaction of HslU with the HslV peptidase. Moreover, electron density for the portion of the I domain in which the L199Q mutation resides is absent in both the wild type and L199Q structures. Below, we discuss how a mutation in a segment of the I domain that is structurally dynamic might regulate ATP hydrolysis and protein degradation.
The position corresponding to Leu 199 is a hydrophobic residue in HslU orthologs (Fig. 1B) , and the Jpred4 homology-based secondary-structure algorithm (Drozdetskiy et al., 2015) strongly predicts that it is part of an amphipathic α-helix, extending from residues 193-204. Because this region can be proteolytically cleaved in WT HslU but becomes substantially more susceptible to cleavage in L199Q HslU, we propose that this helix transiently unravels in the wild-type enzyme but is largely unfolded in the mutant because the L199Q substitution disrupts hydrophobic interactions required for helix stability. We refer to the 193-204 region as a "gating" helix, although the argument that follows is not dependent upon specific structural details. Based upon the flanking well-ordered regions of the I domain, the gating helix would fill part of the lumen of a funnel-shaped cavity above the axial pore of the AAA + ring, and any protein substrate would need to traverse this funnel to reach the axial pore of HslU (Fig. 1A) .
ATP-hydrolysis drives power strokes in the AAA+ ring of HslU and the related ring of ClpX that involve movements of rigid-body units, comprising a large AAA+ domain and a neighboring small AAA+ domain, with respect to each other (Wang et al., 2001b; Glynn et al., 2009; . If the gating helices contribute to interactions between neighboring I domains that need to be broken to allow a power stroke, then the L199Q mutation could accelerate ATP hydrolysis simply by lowering the energy barrier for this rate-limiting conformational change. Alternatively, part of the gating helix might suppress ATP hydrolysis more directly by interacting with the AAA+ ring. Again, mutational disruption of such interactions could plausibly be responsible for increasing the ATP-hydrolysis rate of L199Q HslU.
One striking property of L199Q HslUV is that it prefers to begin degradation at the C-terminus of the model substrates tested, whereas WT HslUV prefers to initiate degradation at the Nterminus of these substrates. Because the mechanical stability of protein substrates can depend on the direction of pulling by a AAA+ enzyme (Lee et al., 2001; Kenniston et al., 2004; Gur et al., 2012) , this change in directionality combined with faster ATP hydrolysis probably accounts for our finding that L199Q HslUV degrades some substrates faster than WT HslUV. Similarly, for substrates easier to unfold from the N-terminus, L199Q HslUV would be expected to be a poorer protease than WT HslUV. Although structures of wild-type or L199Q HslU in complex with substrates may ultimately be needed to understand this change in directionality, we suggest that mutational disruption of the gating helices might affect directionality by reducing binding to certain degrons and/or improving binding to other degrons. For example, the native gating helix in WT HslU might preferentially bind Cterminal sequences of an Arc substrate, allowing the N-terminal residues to bind in the axial pore. Disruption of the gating helix in L199Q HslU might then allow either the C-terminus or N-terminus of the substrate to be engaged by the pore. This model would result in faster L199Q HslU degradation for substrates that are easier to unfold from the C-terminus than the N-terminus. Sites that are unmasked by disruption of the gating helices could also alter binding of N-terminal or C-terminal substrate sequences. For example, a binding or engagement site for the sul20 tag in the HslU pore might be unmasked in L199Q HslU, explaining why L199Q HslUV robustly degrades sul20-tagged substrates. Both types of models are consistent with our observation that WT HslUV and L199Q HslUV can each degrade the same substrates, albeit often with very different efficiencies. Indeed, the binding of certain substrates might preferentially stabilize or destabilize the gating helices, altering how these proteins are engaged and degraded by HslU.
Although our models can account for changes in ATPase and degradation properties of L199Q HslUV in vitro, they do not explain why this mutation prevents degradation of SulA in vivo (Lien et al., 2009 ). Indeed, we find that L199Q HslUV degrades proteins bearing the C-terminal 20-residues of SulA faster than WT HslUV does at saturating substrate concentrations and with a higher second-order rate constant (V max /K M ) at low substrate concentrations. In E. coli, SulA binds to FtsZ (Jones and Holland, 1985) , and HslU may need to recognize both the N-and C-termini of SulA for efficient extraction of SulA from the complex and subsequent degradation. Alternatively, L199Q HslU may be expressed at somewhat lower levels in vivo, competitively engage other substrates more efficiently, thereby slowing SulA degradation, or expose hydrophobic residues that result in the recruitment of cellular chaperones, thereby blocking substrate binding and engagement in the cell. 
Methods
Cloning, expression, and protein purification
Unless noted, standard polymerase-chain-reaction techniques were used for cloning and sitedirected mutagenesis. Genes encoding wild-type HslU or L199Q HslU with N-terminal H 6 tags were expressed from pET12b vectors (Novagen). The pET21b vector (Novagen) was used to express Arc, followed by a cysteine, followed by one of three tags: H 6 , st11-ssrA (H 6 KNQHDAANDENYALAA), or st11-sul20 (H 6 KNQHDASSHATRQLSGLKIHSNLYH). A pET21b plasmid expressing I37A Arc-cp6 GFP-st11-ssrA was a gift from Jiejin Chen (MIT); a related vector expressing Arc-cp6 GFP-st11-ssrA was generated by reversing the I37A mutation. NC11 Arcst11-sul20 contains a glycine between residues Met 1 and Lys 2 of wild-type Arc, has a slightly different st11 tag (H 6 KNQHE), and was expressed from a pACYC-Duet plasmid constructed by Matthew Wohlever (MIT).
H 6 -tagged variants of HslU 6 and HslV 12 were overexpressed in E. coli strain X90 (λDE3) slyD::kan hslUV::tet and purified by Ni ++ -NTA affinity, ion-exchange, and gel-filtration chromatography using minor modifications of a published procedure (Sundar et al., 2010) .
Cell pellets were resuspended and lysed in buffer A (50 mM Tris, pH 7.5, 300 mM NaCl, 20 mM imidazole, 0.5 mM DTT, 0.5 mM EDTA), and 1.5 µL benzonase (250 units/µL, Sigma) per liter of culture was added. Lysates were cleared by centrifugation, polyethyleneimine was added to the supernatant to a final concentration of 0.1% (v/v), and precipitated material was removed by centrifugation. Proteins were eluted from Ni ++ -NTA with buffer B (50 mM Tris, pH 7.5, 300 mM NaCl, 250 mM imidazole, 0.5 mM DTT, 0.5 mM EDTA). The Ni ++ -NTA eluate was diluted with buffer C (50 mM Tris, pH 7.5, 10% (v/v) glycerol, 1 mM EDTA, 1 mM DTT), loaded onto a MonoQ 10/100 GL column (GE Healthcare), and eluted with a linear gradient from 0.15 to 0.5 M NaCl in buffer C. Appropriate fractions from the monoQ column were pooled, concentrated, and loaded onto a HiLoad Superdex 200 16/60 column (GE Healthcare) equilibrated in buffer D (50 mM Tris, pH 7.5, 300 mM NaCl, 10% (v/v) glycerol, 1 mM EDTA, 1 mM DTT). Fractions from this column were monitored by SDS-PAGE, and those containing HslU or HslV (> 95% purity) were pooled, concentrated, aliquoted, and frozen at -80 °C until use. HslU concentrations were calculated for hexamer equivalents; HslV concentrations were calculated for dodecamer equivalents.
Plasmids expressing Arc-cys-st11-ssrA, Arc-cys-st11-sul20, or NC11 Arc-st11-sul20 were transformed into E. coli strain X90 (λDE3) slyD::kan hslUV::tet, grown to an OD 600 of 0.6-0.8 at 37 °C, 1 mM IPTG was added to induce protein expression, and growth was continued for 4 h at room temperature. Cells were resuspended, lysed, and the Arc substrates were purified by Ni ++ -NTA affinity chromatography as described above for the HslU purification. For further purification, Arc-cys-st11-ssrA was diluted with an appropriate volume of buffer C to an ionic strength equivalent to 100 mM NaCl, loaded onto a Source 15S column (GE Healthcare), and eluted with a linear gradient from 0.1 to 0.5 M NaCl in buffer C. Appropriate fractions were pooled, exchanged into buffer D, concentrated, and frozen at -80 °C. For additional purification, Arc-cys-st11-sul20 or NC11 Arc-st11-sul20 was chromatographed on a HiLoad Superdex 75 16/60 column (GE Healthcare) equilibrated in buffer D. Appropriate fractions were pooled, diluted with 0.66 volumes of buffer C, loaded onto the Source 15S column, and eluted with a linear gradient from 0.2 to 0.6 M NaCl in buffer C. Arc-GFP-st11-ssrA and I37A Arc-GFP-st11-ssrA were purified in the same manner as Arc-cys-st11-ssrA except an additional gel-filtration step using a HiLoad Superdex 200 16/60 equilibrated in buffer D was performed. Arc-Gcn4-st11-ssrA was purified as described (Baytshtok et al., 2015) . Arc-Gcn4-st11-sul20 was purified as described for Arc-Gcn4-st11-ssrA. Monomeric, H 6 -tagged SspB contained the L6R, R9E, Y12Q, L13K, A16E, F17K, W20E, and D23K mutations (McGinness et al., 2007 ) and was purified as described for Arccys-st11-ssrA except a monoQ 10/100 GL column was used for the ion-exchange step.
Electron microscopy
HslUV complexes were assembled by mixing wild-type or L199Q HslU (1 µM), HslV (0.5 µM), and freshly prepared ATPγS (5 mM) in 20 mM HEPES, pH 7.5, 5 mM MgCl 2 , 500 mM NaCl, 10% glycerol (v/v), and 0.032% NP40. After 15 min at room temperature, the mixture was diluted 10-times in EM buffer (20 mM HEPES, pH 7.5, 5 mM MgCl 2 , 500 mM NaCl and 5 mM ATPγS) and immediately applied on formvar/carbon grids, and stained with 0.7% uranyl formate. Electron micrographs of single particles were recorded with a 2k×2k Gatan CCD using a FEI Tecnai T12 instrument at 120 kev with a magnification of 67000×. Relion1.3 (Scheres, 2012a; 2012b) was used for single-particle picking, particle extraction, and reference-free 2D class averages. CTFFIND4 (Rohou and Grigorieff, 2015) was used to estimate contrast transfer functions. For WT HslUV, 10235 particles from 25 micrographs were picked initially, and 5200 particles were used to generate representative 2D class averages. For L199Q HslUV, 6164 particles from 26 micrographs were picked initially, and 3313 particles were used to generate representative 2D class averages.
Crystallization and structure determination
H 6 -tagged L199Q HslU and HslV were exchanged into buffer X (15 mM Tris, pH 7.5, 100 mM NaCl, 20 mM MgCl 2 , 0.2 mM EDTA) using Micro Bio-Spin 6 (Bio-Rad) columns and mixed with Arc-st11-ssrA and 5 mM ATP to a final concentration of 25 µM L199Q HslU (7.5 mg/mL), 40 µM HslV (9.7 mg/mL), and 60 µM Arc-st11-ssrA (0.5 mg/mL). Hanging drops containing 0.5 µL of this mixture and 0.5 µL of the mother liquor (100 mM Bis-Tris, pH 5.5, 1.8 M ammonium sulfate) were incubated at 4 °C for crystallization. Large hexagonal crystals appeared within 1-2 days. Diffraction data for the L199Q HslUV crystal were collected at the Advanced Photon Source (APS) beamline 24-ID-E at 100 K (wavelength 0.9792 Å) and were processed using HKL2000 (Otwinowski and Minor, 1997) . The structure was solved by molecular replacement using PHASER (McCoy et al., 2007) and the 1G4A HslUV structure (Wang et al., 2001a ) as a search model. Structure factors for rerefinement of 1G4A were obtained from the Protein Data Bank. All refinement was performed using PHENIX with Cartesian non-crystallographic restraints for identical chains in the asymmetric unit (Adams et al., 2010) , model building was carried out using COOT (Emsley and Cowtan, 2010) , and MolProbity was used to assess model geometry .
Fluorescent labeling of Arc-cys variants
Prior to labeling, a G25 column (GE Healthcare) was used to exchange Arc-cys-st11-ssrA into buffer E (50 mM Tris, pH 7.5, 300 mM NaCl, 1 mM EDTA) or to exchange Arc-cysst11-sul20 into buffer F (50 mM Tris, pH 7.5, 300 mM NaCl, 5% (v/v) glycerol, 0.032% (v/v) Igepal CA-630, 1 mM EDTA). Alexa488-C5-maleimide (Thermo Fisher) was added to the buffer-exchanged samples in a 4:1 molar ratio of fluorophore to protein (in monomer equivalents), and the reaction was incubated in the dark for 2 h at room temperature. The reaction was quenched by addition of 5 mM DTT, and the labeled product was sequentially chromatographed on a PD-10 desalting column (GE Healthcare) and a HiLoad Superdex 75 16/60 column, both equilibrated in buffer D. Appropriate Superdex-75 fractions were pooled, concentrated, and the final concentration was determined by the Bradford assay (Bio-Rad) using unlabeled Arc-cys variants as standards.
Crosslinked NC11 Arc-st11-sul20 dimer NC11 Arc-st11-sul20 was exchanged into buffer F using sequential Micro Bio-Spin 6 columns. Bismaleimidoethane (BMOE, Thermo Scientific) was added to a concentration of 1 mM to the sample, the reaction was incubated for 2 h at room temperature, 5 mM DTT was added as a quencher, and the protein was exchanged into buffer D using a Micro BioSpin 6 column. SDS-PAGE showed that the crosslinking reaction was >98% complete. For stability measurements, samples of non-crosslinked or BMOE-crosslinked NC11 Arc-st11-sul20 (5 µM each) were incubated with increasing concentrations of guanidine hydrochloride in buffer G (50 mM Tris, pH 7.5, 300 mM NaCl, 1 mM EDTA, 5 mM DTT).
After 20 h at room temperature, tryptophan fluorescence was excited at 295 nm, the emission spectra from 300 to 400 nm emission was taken using a PTI QM-2000-4SE spectrofluorimeter, and the center of fluorescence spectral mass was calculated to measure unfolding (Robinson and Sauer, 2000) .
Biotinylation
NC11 Arc-st11-sul20 and Arc-cys-st11-sul20 were exchanged into buffer F using sequential
Micro Bio-Spin 6 columns, EZ-link maleimide-PEG2-biotin (Thermo Scientific) was added to a final concentration of 2 mM, and the reaction was incubated at room temperature for 1.5 h before quenching with 10 mM dithiothreitol. Biotinylated proteins were then exchanged into buffer D using sequential Micro Bio-Spin 6 columns.
Biochemical assays
Assays were performed in PD buffer (25 mM HEPES, pH 7.5, 5 mM KCl, 20 mM MgCl 2 , 10% glycerol, 0.032% Igepal CA-630) unless noted. ATPase rates at 37 °C were measured using a Spectramax M5 plate reader (Molecular Devices) by monitoring changes in absorbance at 340 nm using an NADH-coupled assay (Nørby, 1988) . Cleavage of Z-GlyGly-Leu-AMC (200 µM; Santa Cruz Biotechnology, Inc.) by HslV (5 nM) was measured at 25 °C in the presence of 5 mM ATP and varying concentrations of HslU using a Spectramax M5 plate reader (excitation 380 nm; emission 455 nm).
Unless noted, degradation experiments monitored by SDS-PAGE were performed at 37 °C with 5 mM ATP and an ATP-regeneration system (16 mM creatine phosphate, 10 µg/mL creatine kinase). Degradation of GFP variants tagged with Arc, I37A Arc, or sul20 was monitored by loss of fluorescence (excitation 467 nm; emission 511 nm). Degradation of Arc-cysA-st11-ssrA and Arc-cysA-st11-sul20 variants labeled with Alexa488 was monitored by increase in fluorescence (excitation 480 nm; emission 520 nm) on a Spectramax M5 plate reader at 37 °C in the presence of 5mM ATP and an ATP-regeneration system. When degradation of Arc-cysA variants did not go to completion, trypsin was added to a final concentration of 40 µg/mL to obtain the final fluorescence values. Rates for degradation of the Arc-cysA variants were calculated by dividing the initial linear slope by the total amplitude of the fluorescence change, and multiplying this quotient by the concentration of substrate. Degradation of biotinylated NC11 Arc-st11-sul20 or Arc-cys-st11-sul20 (15 µM each) was performed in the presence of streptavidin tetramer (25 µM; Sigma, salt-free). At different times, aliquots were taken, added to SDS-PAGE loading buffer containing 10 mM d-biotin, and heated at 80 °C for 5 min before gel electrophoresis. Degradation of ArcmDHFR-barnase-st11-sul20 was performed at 30 °C in the presence of 100 µM methotrexate.
Limited proteolysis experiments were performed at 37 °C in the presence of 5 mM ATP, 5 mM ADP, or the absence of nucleotide. HslU (0.5 µM) was pre-incubated with ATP in the presence or absence of HslV (1 µM) for 30 s and 11 nM subtilisin (Carlsberg variant; Sigma Aldrich) or 60 nM chymotrypsin (TLCK-treated, Worthington Biochemical Corporation) was added. Aliquots were taken at different times and mixed with SDS-PAGE loading buffer to quench the reaction. To purify subtilisin cleavage products for LC MS/MS, the reaction was quenched after 6 min by the addition of 1 mM phenylmethylsulfonyl fluoride (PMSF), diluted with buffer H (50 mM Tris, pH 7.5, 7 M urea, 1 mM DTT, 1 mM EDTA), loaded onto a source 15Q column (GE Healthcare), and eluted with a linear gradient from 0.1 to 1.0 M NaCl in buffer H. A peak containing the major fragments was run on SDS-PAGE, the ∼25 kDa bands were extracted from the gel and digested with trypsin, and LC MS/MS analysis was performed by the MIT Koch Institute Biopolymers and Proteomics Core Facility. To purify chymotrypsin cleavage products, the reaction was quenched after 6 min by addition of 1 mM PMSF, H 6 -tagged proteins and associated partners were bound to Ni ++ -NTA affinity in buffer A, and proteins eluted with buffer B were subjected to MALDI-TOF analysis by the MIT Koch Institute Biopolymers and Proteomics Core Facility. For sequential Edman degradation, L199Q HslU was incubated with chymotrypsin for 6 min, reaction products were separated by SDS-PAGE, and the top band of a doublet running near 25 kDa was excised from the gel and submitted to the Tufts Core Facility for sequencing. The rate of hydrolysis of 5 mM ATP at 37 °C was assayed for L199Q HslU and WT HslU (300 nM each) in the absence or presence of HslV (900 nM) using a coupled assay (Nørby, 1988 Table 2 ). Values are averages of 3 independent replicates ± 1 SD. (B) Degradation of I37A Arc-cp6 GFPst11-ssrA by WT HslUV and L199Q HslUV (fitted parameters in Table 2 ). (C) The energetic efficiency of substrate degradation was determined by dividing the ATPase rate in the presence of near saturating substrate by the maximal degradation rate. Rates of ATP hydrolysis by WT HslUV and L199Q HslUV were determined in the presence of Arc-cp6 GFP- crosslinked N11C Arc-st11-sul20, Arc-Gcn4-st11-sul20, and Arc-Gcn4-st11-ssrA by WT HslUV and L199Q HslUV. Rates were determined by single-exponential fits of substrate remaining versus time determined by densitometry of the gels in panels B-E plus two additional independent replicates for each substrate. The values plotted are averages of the three replicates ± SD. (F) Michaelis-Menten plot for degradation of cp7 GFP-sul20 by WT HslUV or L199Q HslUV (500 nM HslU; 1000 nM HslV). Values are averages (n=3) ± SD. Fitted parameters for L199Q HslUV are listed in Table 2 . For WT HslUV, the line is a linear function and K M and V max were not determined. All degradation assays were performed at 37 °C in the presence of 5 mM ATP. HslUV degradation of ArcmDHFR-barnase-st11-sul20 (5 µM) in the presence of 100 µM methotrexate. In all panels, the concentrations of HslU and HslV were 500 nM and 1000 nM, respectively and ATP was present at 5 mM. Assays were done at 37 °C in panels A and B and at 30 °C in panel C. Table 1 Crystallographic scaling and refinement statistics R free equivalent to R work except calculated over ∼5% of the data in the test set.
Structure. Author manuscript; available in PMC 2017 October 04.
